views

Oxford Nanopore – is this low growth cash guzzler really worth £1.45 billion? Dismal results posted!

Its association with Neil Woodford and its constant hyping, no rather sordid slavering adulation, by the deadwood press always lead me to treat Oxford Nanopore (ONT) with real suspicion. Institutional investors bundled in at 425p in its September 2021 IPO. Today the shares are just 176p but piss poor results suggest even that valuation is mighty generous.

NEWSFLOW

Oxford Nanopore (#ONT) – 2021 increased loss, “expected significant decline in COVID-19 sequencing revenue in 2022”

views

As DNA Research becomes Ever More Vital, this British Pioneer Is Set to Cash in

Hello, Share Fans. What would TV be without DNA? Not only does the magic technology feature big time in most crime dramas but it’s also used in tracking down ancestors, the object of quite a few documentary series these days. Which leads me to look at a DNA sequencing company called Oxford Nanopore (ONT).

views

Oxford Nanopore – forget the broker hype – look what the insiders are doing

The IPO of Oxford Nanopore (ONT) was Christmas came early for the brokers involved.. Raising £1.87 billion of either new cash or from flogging shares for exiting shareholders at 425p will have generated almost £90 million in commission which, even in these inflationary times, will buy an awful lot of coke and upper class hookers. To support such an exercise there were numerous enthusiastic buy notes.  So with the shares now at 577p should we believe the bullshit buy notes?

NEWSFLOW

Oxford Nanopore (#ONT) – commences trading on main market Standard List